MDS Capital
North America, New York, United States, New York
Description
MDS Capital Corp. was established in 1988 to participate in the financing and development of health-related technologies.
Investor Profile
MDS Capital has backed more than 33 startups, with 0 new investments in the last 12 months alone. The firm has led 5 rounds, about 15% of its total and boasts 19 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series A rounds (top funding stages).
- Majority of deals are located in United States, Canada.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series B (27%)
- Series C (21%)
- Series A (18%)
- Series D (15%)
- Series Unknown (12%)
- Series E (3%)
- Debt Financing (3%)
Country Focus
- United States (79%)
- Canada (21%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Pharmaceutical
- Medical Device
- Biopharma
- Health Diagnostics
- Therapeutics
- Information Technology
- Innovation Management
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
